The Company's full financial statements and related MD&A for the first quarter ended September 30, 2024, are available at www.inmedpharma.com, www.sedar.com and at www.sec.gov.

The Inland Revenue Authority of Singapore (IRAS) started investigations into the funeral industry and its related services - ...

The thing that shocks my friends in the Silicon Valley is not just our performance, but that we trained the model with only ...

After reaching a $6.01 billion deal with 3M to settle the largest mass tort litigation in U.S. history, lawyers for the ...

New data from the IVCA shows VC funding in Ireland for the nine months to the end of September fell by 18% to €945.3m from €1 ...

Peter Kjome's experience as a professional oboist has been instrumental in his role as a business leader, including as ...

Fintel reports that on November 13, 2024, UBS upgraded their outlook for 3M (NYSE:MMM) from Neutral to Buy. Analyst Price ...

UBS last night upgraded 3M (MMM) to Buy from Neutral with a price target of $184, up from $130, after assuming coverage of the name. The analyst believes the company’s new outsider CEO, William Brown, ...

Fintech startup Zeplyn's flagship product, a platform-agnostic meeting assistant, reportedly saves advisors 10 to 12 hours ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $152.5, a high estimate of ...

Chemicals company 3M Co., which runs a plant in Detroit, maintains that the Michigan Department of Environment, Great Lakes, ...

The United States Agency for International Development (USAID) has pledged a $2.3 million investment aimed at acquiring doses ...